Fortress Biotech Inc (NASDAQ: FBIO) kicked off on Monday, up 9.76% from the previous trading day, before settling in for the closing price of $2.05. Over the past 52 weeks, FBIO has traded in a range of $1.36-$4.43.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 26.66%. While this was happening, its average annual earnings per share was recorded 58.60%. With a float of $21.92 million, this company’s outstanding shares have now reached $27.58 million.
Let’s determine the extent of company efficiency that accounts for 186 employees. In terms of profitability, gross margin is 59.95%, operating margin of -169.77%, and the pretax margin is -162.85%.
Fortress Biotech Inc (FBIO) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Fortress Biotech Inc is 20.58%, while institutional ownership is 16.55%. The most recent insider transaction that took place on Sep 23 ’24, was worth 1,404,581. In this transaction PRESIDENT, CEO & CHAIRMAN of this company bought 763,359 shares at a rate of $1.84, taking the stock ownership to the 3,657,264 shares. Before that another transaction happened on Jul 11 ’24, when Company’s President, CEO & Chairman bought 5,000 for $7.48, making the entire transaction worth $37,418. This insider now owns 127,500 shares in total.
Fortress Biotech Inc (FBIO) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 58.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.50% during the next five years compared to 22.28% growth over the previous five years of trading.
Fortress Biotech Inc (NASDAQ: FBIO) Trading Performance Indicators
Take a look at Fortress Biotech Inc’s (FBIO) current performance indicators. Last quarter, stock had a quick ratio of 1.06. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.27, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -1.48 in one year’s time.
Technical Analysis of Fortress Biotech Inc (FBIO)
Looking closely at Fortress Biotech Inc (NASDAQ: FBIO), its last 5-days average volume was 0.77 million, which is a jump from its year-to-date volume of 0.41 million. As of the previous 9 days, the stock’s Stochastic %D was 69.58%. Additionally, its Average True Range was 0.15.
During the past 100 days, Fortress Biotech Inc’s (FBIO) raw stochastic average was set at 58.31%, which indicates a significant decrease from 88.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.04% in the past 14 days, which was higher than the 81.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.76, while its 200-day Moving Average is $1.86. However, in the short run, Fortress Biotech Inc’s stock first resistance to watch stands at $2.33. Second resistance stands at $2.40. The third major resistance level sits at $2.54. If the price goes on to break the first support level at $2.12, it is likely to go to the next support level at $1.98. Should the price break the second support level, the third support level stands at $1.91.
Fortress Biotech Inc (NASDAQ: FBIO) Key Stats
The company with the Market Capitalisation of 61.96 million has total of 27,605K Shares Outstanding. Its annual sales at the moment are 84,510 K in contrast with the sum of -60,640 K annual income. Company’s last quarter sales were recorded 14,630 K and last quarter income was -12,870 K.
